Friday, November 20, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Medicine

SGLT2 Induction in Vascular Cells May Drive Cardiovascular Dysfunction

November 8, 2026
in Medicine
Ophelia Keating
By Ophelia Keating Scienmag Editorial Profile - Health Services Research
Reading Time: 3 mins read
0
SGLT2 Induction in Vascular Cells May Drive Cardiovascular Dysfunction

SGLT2 Induction in Vascular Cells May Drive Cardiovascular Dysfunction

65
SHARES
587
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

A review published in Cardiovascular Diabetology on October 10, 2026, proposes that sodium-glucose cotransporter 2 (SGLT2) is not merely a renal protein but an inducible player in endothelial dysfunction and cardiovascular disease. The article, authored by Antonin Trimaille, Sophie Kerth, and colleagues, synthesizes recent data indicating that SGLT2 expression in extra-renal tissues, including endothelial cells, is dynamic rather than constitutive. This perspective challenges the long-standing view that SGLT2 is predominantly expressed in renal proximal tubules and offers a mechanistic framework for understanding the broad cardiovascular benefits of SGLT2 inhibitors beyond their glucose-lowering effects.

SGLT2 inhibitors were initially developed as glucose-lowering agents for type 2 diabetes but have rapidly emerged as foundational therapies in cardiovascular medicine. Large, randomized trials have demonstrated strong reductions in heart failure hospitalization and cardiovascular death across the full spectrum of left ventricular ejection fraction, irrespective of diabetes status. These agents have also shown additional benefits in patients with chronic kidney disease and after acute heart failure decompensation. Beyond heart failure, accumulating evidence suggests potential therapeutic effects in myocardial infarction, atrial fibrillation, cerebrovascular disease, heart valve diseases, and pulmonary hypertension, although the level of evidence remains heterogeneous across these conditions.

The mechanisms underlying these broad benefits remain incompletely understood. The review highlights that recent data indicate low, heterogeneous, and inducible expression of SGLT2 in extra-renal tissues. These tissues include endothelial cells, monocytes, hepatocytes, epicardial adipose-derived preadipocytes, vascular tissue, and cardiomyocytes. In the cardiovascular system, SGLT2 expression appears to be driven by numerous pathological stimuli rather than being present at a constant baseline level.

According to the authors, induction of SGLT2 is driven by oxidative stress, metabolic stress, angiotensin II, thrombin and factor Xa, sympathetic nervous system stress, inflammatory cytokines, low-grade inflammation disease-associated plasma, and pro-remodeling signals. Once induced, SGLT2 may contribute to endothelial dysfunction through increased intracellular glucose uptake. More critically, the review posits that SGLT2 acts as a local amplifier within a feed-forward circuit involving NADPH oxidases and the renin-angiotensin system. This interaction disrupts the balance between endothelial nitric oxide synthase (eNOS) and reactive oxygen species (ROS), specifically the eNOS-NO/ROS balance.

The disruption of this balance drives NF-κB-mediated inflammation, cellular senescence, pro-thrombotic activation, vascular remodeling, fibrosis, and calcification. These processes may contribute to a stress-induced cycle that amplifies oxidative and inflammatory injury. The review integrates these mechanistic insights with the well-established renal and systemic actions of SGLT2 inhibitors. By understanding the inducible cardiovascular biology of SGLT2, researchers may better explain the pleiotropic benefits of these drugs.

The study type is a review, summarizing current evidence on the distribution, regulation, and cardiovascular consequences of SGLT2 expression. The scope includes both mechanistic insights and clinical data, aiming to bridge the gap between molecular biology and therapeutic outcomes. The authors note that extra-renal SGLT2 expression remains debated and poorly characterized, which is why this integrative review is significant. The key research question addressed is whether SGLT2 is an inducible mediator of endothelial dysfunction in cardiovascular disease. The review concludes that cardiovascular SGLT2 appears low at baseline but is inducible by pathological stress, and that induced SGLT2 may amplify oxidative stress, inflammation, and senescence.

This pathway may also promote thrombosis, fibrosis, and vascular calcification, contributing to the overall burden of cardiovascular disease. The framework presented in the review may guide future biomarker studies and broader cardiovascular use of SGLT2 inhibitors. The review emphasizes that the cardiovascular benefits of SGLT2 inhibitors are not fully explained by renal actions alone, supporting the need to investigate extra-renal mechanisms.

The publication is open access and citable, carrying a permanent DOI, though it is noted as an early version subject to further edits. The review underscores the importance of understanding the dynamic expression of SGLT2 in diseased cardiovascular tissues.

Subject of Research: Inducible SGLT2 expression in extra-renal tissues and its role in endothelial dysfunction and cardiovascular disease mechanisms.

Article Title: SGLT2 beyond the kidney: an inducible player in endothelial dysfunction and cardiovascular diseases

Article References: Trimaille, A., Kerth, S., Mroueh, A., Fakih, W., Hmadeh, S., Muzammel, H., Jesel, L., Görlach, A., Morel, O., & Schini-Kerth, V. (2026). SGLT2 beyond the kidney: an inducible player in endothelial dysfunction and cardiovascular diseases. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-026-03394-8

Image Credits: AI Generated

DOI: 10.1186/s12933-026-03394-8

Keywords: SGLT2, endothelial dysfunction, cardiovascular disease, oxidative stress, inflammation, vascular biology, heart failure, drug mechanisms, review article, beyond, kidney, inducible

Cite Scienmag News

Ophelia Keating. (November 8, 2026). SGLT2 Induction in Vascular Cells May Drive Cardiovascular Dysfunction. Scienmag. https://scienmag.com/sglt2-induction-in-vascular-cells-may-drive-cardiovascular-dysfunction/

Ophelia Keating. "SGLT2 Induction in Vascular Cells May Drive Cardiovascular Dysfunction." Scienmag, 8 November 2026, https://scienmag.com/sglt2-induction-in-vascular-cells-may-drive-cardiovascular-dysfunction/. Accessed 20 November 2026.

Ophelia Keating. "SGLT2 Induction in Vascular Cells May Drive Cardiovascular Dysfunction." Scienmag. November 8, 2026. https://scienmag.com/sglt2-induction-in-vascular-cells-may-drive-cardiovascular-dysfunction/

Tags: Beyondcardiovascular diseasedrug mechanismsendothelial dysfunctionheart failureinducibleinflammationkidneyOxidative stressreview articleSGLT2vascular biology
Share26Tweet16
Previous Post

High activity of factor XI and C1 inhibitor in patients with ANCA-associated vasculitis: clinical and laboratory correlations with follow-up analysis of thrombotic events

Next Post

A coupled model to value indirect impacts of maternal, newborn and child health interventions

Related Posts

Surgical Patients in Ghana Face Routine Preoperative Procedures Without Adequate Information
Medicine

Surgical Patients in Ghana Face Routine Preoperative Procedures Without Adequate Information

November 20, 2026
Audit Identifies Limitations in Head and Neck Cancer Efferocytosis Gene Scores
Cancer

Audit Identifies Limitations in Head and Neck Cancer Efferocytosis Gene Scores

November 20, 2026
Pilot Trial Compares Rapid and Three-Month Glycemic Preparation for Penile Implants
Medicine

Pilot Trial Compares Rapid and Three-Month Glycemic Preparation for Penile Implants

November 20, 2026
Elastic Nanovesicle Gel Delivers Vardenafil to Relieve Peripheral Tissue Ischemia
Medicine

Elastic Nanovesicle Gel Delivers Vardenafil to Relieve Peripheral Tissue Ischemia

November 20, 2026
Thai and Migrant Pregnancy Care Remained Resilient During the Pandemic
Medicine

Thai and Migrant Pregnancy Care Remained Resilient During the Pandemic

November 20, 2026
Special Issue Evaluates Nanomaterial Targeting Strategies and Formulation Trade-Offs in Drug Delivery
Medicine

Special Issue Evaluates Nanomaterial Targeting Strategies and Formulation Trade-Offs in Drug Delivery

November 20, 2026
Next Post
Research report: A coupled model to value indirect impacts of maternal, newborn and child health interventions

A coupled model to value indirect impacts of maternal, newborn and child health interventions

  • Mothers who receive childcare support from maternal grandparents show more optimized

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27656 shares
    Share 11059 Tweet 6912
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1061 shares
    Share 424 Tweet 265
  • Bee body mass, pathogens and local climate influence heat tolerance

    682 shares
    Share 273 Tweet 171
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    546 shares
    Share 218 Tweet 137
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    531 shares
    Share 212 Tweet 133
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Adaptive Solution Spaces Preserve Parallel Engineering in Vehicle Crashworthiness Design
  • Extraterrestrial Helium Tracks Ancient Ocean Sediment Accumulation Across the Cenozoic
  • Outdoor Broiler Housing Increases Feed Costs While Altering Meat and Bone Quality
  • Blueberry Byproduct Pigments Effectively Color Clean-Label Cherries Across Storage Testing

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Science News
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,151 other subscribers

© 2026 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2026 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading